Page 10 of 22
GEMS – February 2017
GEMS informs policies and defines programmatic considerations related to use of ARV-based HIV prevention products and risk of resistance. Genital swabs testing begins and assay development is underway. Initial oral PrEP modeling completed. Collaboration in Kenya and Namibia continues. Genital swabs testing begins and assay development is underway. GEMS has collaborated with Partners PrEP and… Read more »
February 27, 2017
MPii presents at CROI 2017
OPTIONS presented two posters at CROI 2017 in February focused on modeling work in Kenya: “Cost-effectiveness of pre-exposure prophylaxis across counties in Western Kenya” and “HIV transmission in generalized, concentrated, and mixed epidemics in Western Kenya.” GEMS also presented the poster, “Does the E138A Mutation in ASPIRE Seroconverters Affect Susceptibility to Dapivirine?”
EMOTION – February 2017
EMOTION increases uptake and correct and consistent use of ARV-based HIV prevention products by women at high risk of HIV infection using an end-user centered strategy. Pilot messaging study completed. Socio-behavioral study underway. Pilot messaging study completed. Project Siyavala, the pilot messaging study, builds on findings from Project Kalahari, which focused on the “End User Journey”… Read more »
Page 10 of 22